This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P160049S016 |
Classification Name | None |
Applicant | |
PMA | P160049 |
Supplement | S016 |
Supplement Number | Date | Supplement Type |
---|---|---|
P160049 | Original Filing | |
S019 | 2022-06-14 | 30-day Notice |
S018 | 2022-04-01 | Normal 180 Day Track No User Fee |
S017 | 2022-03-17 | 30-day Notice |
S016 | ||
S015 | 2021-09-29 | Panel Track |
S014 | ||
S013 | 2021-09-17 | Normal 180 Day Track No User Fee |
S012 | 2021-05-07 | Normal 180 Day Track No User Fee |
S011 | 2021-01-21 | 30-day Notice |
S010 | ||
S009 | ||
S008 | 2020-01-15 | 30-day Notice |
S007 | 2019-09-03 | Special (immediate Track) |
S006 | 2019-05-13 | 30-day Notice |
S005 | 2019-04-08 | 30-day Notice |
S004 | ||
S003 | 2018-10-01 | Normal 180 Day Track No User Fee |
S002 | 2018-01-22 | Real-time Process |
S001 | 2017-09-01 | Real-time Process |